# Antigen Rapid Diagnostic Tests for Community Identification of Severe Acute Respiratory Syndrome Coronavirus 2

> **NCT05458557** · — · COMPLETED · sponsor: **Elizabeth Glaser Pediatric AIDS Foundation** · enrollment: 5000 (actual)

## Conditions studied

- Severe Acute Respiratory Syndrome Coronavirus 2 Infection

## Interventions

- **DIAGNOSTIC_TEST:** Rapid Antigen Testing

## Key facts

- **NCT ID:** NCT05458557
- **Lead sponsor:** Elizabeth Glaser Pediatric AIDS Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-20
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-12-16
- **Target enrollment:** 5000 (ACTUAL)
- **Last updated:** 2023-04-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05458557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05458557, "Antigen Rapid Diagnostic Tests for Community Identification of Severe Acute Respiratory Syndrome Coronavirus 2". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05458557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*